Evelyn Flynn

Boston Children's Hospital — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

38h-index13.9kcitations93works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Angiogenesis and VEGF in Cancer(23), Signaling Pathways in Disease(16), Biochemical and Molecular Research(12), Enzyme function and inhibition(10), Cell Adhesion Molecules Research(9)

Publications93 total

Pregnancy outcomes of Ukrainian displaced women in Dublin.
PubMed·2024
Pudgy mouse rib deformities emanate from abnormal paravertebral longitudinal cartilage/bone accumulations
Biology Open·2024Open Access
Data from Overexpression of Vascular Endothelial Growth Factor and the Development of Post-Transplantation Cancer
2023Open Access
Supplementary Figure 3 from Overexpression of Vascular Endothelial Growth Factor and the Development of Post-Transplantation Cancer
2023Open Access
Supplementary Figure 1 from Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer Cells
2023Open Access
Supplementary Figure 5 from Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer Cells
2023Open Access
Supplementary Figure 4 from Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer Cells
2023Open Access
Supplementary Figure 2 from Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer Cells
2023Open Access
Supplementary Figure 3 from Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer Cells
2023Open Access
Supplementary Figure 4 from Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer Cells
2023Open Access
Supplementary Figure 3 from Overexpression of Vascular Endothelial Growth Factor and the Development of Post-Transplantation Cancer
2023Open Access
Data from Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer Cells
2023Open Access
Data from Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer Cells
2023Open Access
Supplementary Figure 1 from Overexpression of Vascular Endothelial Growth Factor and the Development of Post-Transplantation Cancer
2023Open Access
Supplementary Figure 1 from Overexpression of Vascular Endothelial Growth Factor and the Development of Post-Transplantation Cancer
2023Open Access
Supplementary Figure 2 from Overexpression of Vascular Endothelial Growth Factor and the Development of Post-Transplantation Cancer
2023Open Access
Supplementary Figure 5 from Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer Cells
2023Open Access
Data from Overexpression of Vascular Endothelial Growth Factor and the Development of Post-Transplantation Cancer
2023Open Access
Supplementary Figure 2 from Overexpression of Vascular Endothelial Growth Factor and the Development of Post-Transplantation Cancer
2023Open Access
Supplementary Figure 1 from Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer Cells
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Judah Folkman(15), Robert J. D’Amato(10), Gerald Shklar(8), David M. Briscoe(7), Soumitro Pal(7), David Zurakowski(6), O. Kisker(5), Alan G. Contreras(5), George Szabó(4), Joel Schwartz(4), Dipak Datta(3), Aninda Basu(3), Samik Chakraborty(3), Murugabaskar Balan(3), Yuen Shing(2), William S. Lane(2), Michael Loughnan(2), Nancy Klauber(2), Sareh Parangi(2), Marsha A. Moses(2)